98
Participants
Start Date
August 1, 2001
Primary Completion Date
November 16, 2007
Study Completion Date
February 10, 2009
exemestane
exemestane 25 mg once daily x 1 year
Placebo
placebo once daily x 1 year
Mayo Clinic - Jacksonville, Jacksonville
Mayo Clinic Cancer Center, Rochester
Massachusetts General Hospital Cancer Center, Boston
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston
Beth Israel Deaconess Medical Center, Boston
Brigham and Women's Hospital, Boston
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus
Memorial Hospital of Rhode Island, Pawtucket
Margaret and Charles Juravinski Cancer Centre, Hamilton
Northwestern Ontario Regional Cancer Care at Thunder Bay Regional Health Sciences Centre, Thunder Bay
Princess Margaret Hospital, Toronto
Centre Hospitalier de l'Universite de Montreal, Montreal
Lead Sponsor
NCIC Clinical Trials Group
NETWORK